Core Viewpoint - Rosen Law Firm is reminding investors who purchased Outset Medical, Inc. securities during the specified class period of the upcoming lead plaintiff deadline for a class action lawsuit [2]. Group 1: Class Action Details - The class period for the lawsuit is from August 1, 2022, to August 7, 2024, and investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2][3]. - A class action lawsuit has already been filed, and interested parties must move the court to serve as lead plaintiff by October 28, 2024 [3]. Group 2: Legal Representation - Investors are encouraged to select qualified legal counsel with a proven track record in securities class actions, as many firms may not have the necessary experience or resources [4]. - The Rosen Law Firm has a history of successful settlements, including the largest securities class action settlement against a Chinese company, and has recovered hundreds of millions of dollars for investors [4]. Group 3: Case Allegations - The lawsuit alleges that during the class period, Outset Medical made false or misleading statements regarding its Tablo products, including marketing for unapproved uses and lacking the necessary sales infrastructure [5]. - The claims suggest that these misrepresentations led to adverse impacts on Outset Medical's revenue growth and misled investors about the company's business prospects [5].
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Outset Medical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – OM